{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:22:55Z","timestamp":1788387775188,"version":"build-2803163510"},"reference-count":13,"publisher":"Impact Journals, LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,1,26]]},"DOI":"10.18632\/oncotarget.6913","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T03:05:29Z","timestamp":1452740729000},"page":"3702-3708","source":"Crossref","is-referenced-by-count":48,"title":["Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma"],"prefix":"10.18632","volume":"7","author":[{"given":"Mingjie","family":"Yao","sequence":"first","affiliation":[{"name":"State Key Laboratory of Natural and Biomimetic Drugs, Department of Microbiology and Infectious Disease Center, School of Basic Medicine, Peking University Health Science Center, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingmin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pathology and Hepatology, Beijing 302 Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengmin","family":"Lu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Natural and Biomimetic Drugs, Department of Microbiology and Infectious Disease Center, School of Basic Medicine, Peking University Health Science Center, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,1,13]]},"reference":[{"key":"1","first-page":"CD002799","article-title":"Alpha-foetoprotein and\/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B","volume":"9","author":"Dickinson","year":"2012","journal-title":"The Cochrane database of systematic reviews"},{"key":"2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer","year":"2012","journal-title":"Journal of hepatology"},{"key":"3","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Sherman","year":"2011","journal-title":"Hepatology"},{"key":"4","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.3748\/wjg.v19.i11.1811","article-title":"Value of alpha-fetoprotein in association with clinicopathological features of hepatocellular carcinoma","volume":"19","author":"Yang","year":"2013","journal-title":"World journal of gastroenterology"},{"key":"5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.canlet.2012.11.042","article-title":"Alpha-fetoprotein receptor as an early indicator of HBx-driven hepatocarcinogenesis and its applications in tracing cancer cell metastasis","volume":"330","author":"Zheng","year":"2013","journal-title":"Cancer letters"},{"key":"6","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1002\/ijc.29548","article-title":"Alpha fetoprotein mediates HBx induced carcinogenesis in the hepatocyte cytoplasm","volume":"137","author":"Li","year":"2015","journal-title":"International journal of cancer"},{"key":"7","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1440-1746.2009.05805.x","article-title":"Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region","volume":"24","author":"Ueno","year":"2009","journal-title":"Journal of gastroenterology and hepatology"},{"key":"8","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jhep.2012.01.008","article-title":"Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design","volume":"56","author":"Bruix","year":"2012","journal-title":"Journal of hepatology"},{"key":"9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2036.2009.04200.x","article-title":"Review article: the management of hepatocellular carcinoma","volume":"31","author":"Nelson","year":"2010","journal-title":"Alimentary pharmacology & therapeutics"},{"key":"10","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/gutjnl-2013-306228","article-title":"Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas","volume":"64","author":"Zucman-Rossi","year":"2015","journal-title":"Gut"},{"key":"11","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.ejca.2012.02.065","article-title":"Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection\u2014results from a clinic-based longitudinal cohort","volume":"48","author":"Yang","year":"2012","journal-title":"European journal of cancer"},{"key":"12","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/hep.26739","article-title":"On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir","volume":"59","author":"Wong","year":"2014","journal-title":"Hepatology"},{"key":"13","first-page":"254","article-title":"Zhonghua Gan Zang Bing Za Zhi","volume":"19","author":"[Expert consensus on the scheme of pathological diagnosis of primary liver cancer]","year":"2011","journal-title":"Chinese journal of hepatology"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T17:36:40Z","timestamp":1589218600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,13]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,1,26]]}},"alternative-id":["6913","26784252"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.6913","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,13]]}}}